Literature DB >> 29604172

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays.

G Guidicelli1, J Visentin1,2,3, N Franchini1, C Borg1, P Merville2,3,4, L Couzi2,3,4, J-L Taupin1,2,3.   

Abstract

HLA antibody detection with single antigen flow beads (SAFB) assays is impaired by complement interference whose frequency, predictability and distribution among HLA antigens have not been analyzed in large cohorts. We compared in two patients' cohorts the routine follow-up SAFB profiles obtained in class I (n = 129) and class II (n = 85) with and without ethylenediaminetetraacetic acid (EDTA)-treatment. The presence of complement interference was defined according to the reproducibility of the SAFB assays evaluated with our class I and II routine positive control sera. Interference occurred in 29.5% and 45.9% of patients in class I and II, respectively. In the untreated condition, at serum level, neither the number of positive beads, the highest bead mean fluorescence intensity (MFI) nor MFI at bead level, satisfactorily predicted interference. HLA-C were the least affected among class I beads. HLA-DQ beads were the most affected in class II. At least one antibody specificity was falsely negative without EDTA for about 3% of sera in class I and 9% in class II. EDTA-treatment did not significantly modify the low-MFI strengths (500-3000 range). This study emphasizes the high frequency of complement interference and the importance and advantages of systematically pretreating sera with EDTA before performing SAFB assays.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA antibodies; complement; interference; prozone; single antigen flow beads

Mesh:

Substances:

Year:  2018        PMID: 29604172     DOI: 10.1111/tan.13263

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  1 in total

1.  Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.

Authors:  Mepur H Ravindranath; Edward J Filippone; Grace Mahowald; Carly Callender; Adarsh Babu; Susan Saidman; Soldano Ferrone
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.